Joel D. Cook

527 total citations
7 papers, 273 citations indexed

About

Joel D. Cook is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Joel D. Cook has authored 7 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pathology and Forensic Medicine, 2 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Joel D. Cook's work include Hearing, Cochlea, Tinnitus, Genetics (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper) and Ophthalmology and Eye Disorders (1 paper). Joel D. Cook is often cited by papers focused on Hearing, Cochlea, Tinnitus, Genetics (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper) and Ophthalmology and Eye Disorders (1 paper). Joel D. Cook collaborates with scholars based in United States, United Kingdom and Greece. Joel D. Cook's co-authors include W. King Engel, Lance M. Optican, D. A. Robinson, David S. Zee, Gregory Sivolapenko, R Hussain, Κωνσταντίνος Κωνσταντινίδης, John L. Trotter, Dimitrios Pectasides and D. Skarlos and has published in prestigious journals such as The Lancet, Cancer Research and Annals of Neurology.

In The Last Decade

Joel D. Cook

7 papers receiving 251 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joel D. Cook United States 5 126 108 51 50 38 7 273
A. Komatsuzaki Japan 8 125 1.0× 200 1.9× 40 0.8× 103 2.1× 54 1.4× 18 362
Elena Pretegiani Italy 14 98 0.8× 98 0.9× 96 1.9× 75 1.5× 110 2.9× 32 428
M. Ohno Japan 11 39 0.3× 82 0.8× 64 1.3× 26 0.5× 36 0.9× 18 311
Hilary J. Barratt United Kingdom 9 68 0.5× 128 1.2× 16 0.3× 143 2.9× 19 0.5× 15 268
Nicholas Török United States 12 68 0.5× 320 3.0× 39 0.8× 82 1.6× 8 0.2× 43 462
Janet L. Cohen United States 6 217 1.7× 138 1.3× 77 1.5× 36 0.7× 50 1.3× 7 383
Fatima Shawkat United Kingdom 14 115 0.9× 100 0.9× 194 3.8× 62 1.2× 45 1.2× 32 444
Marc Kuhberg Germany 6 190 1.5× 192 1.8× 102 2.0× 52 1.0× 3 0.1× 9 463
Tae Hoon Kong South Korea 11 56 0.4× 138 1.3× 15 0.3× 50 1.0× 9 0.2× 51 294
Rebecca J. McLean United Kingdom 14 81 0.6× 230 2.1× 273 5.4× 51 1.0× 18 0.5× 30 572

Countries citing papers authored by Joel D. Cook

Since Specialization
Citations

This map shows the geographic impact of Joel D. Cook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel D. Cook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel D. Cook more than expected).

Fields of papers citing papers by Joel D. Cook

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel D. Cook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel D. Cook. The network helps show where Joel D. Cook may publish in the future.

Co-authorship network of co-authors of Joel D. Cook

This figure shows the co-authorship network connecting the top 25 collaborators of Joel D. Cook. A scholar is included among the top collaborators of Joel D. Cook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel D. Cook. Joel D. Cook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Um, Suzane L., Victoria L. Peek, Jennifer R. Stephens, et al.. (2017). Abstract 519: Antitumor activity of MET antibody emibetuzumab (LY2875358) in combination with EGFR inhibitors in erlotinib resistant (ER) xenograft mouse models. Cancer Research. 77(13_Supplement). 519–519. 2 indexed citations
2.
Yan, S. Betty, Suzane L. Um, Victoria L. Peek, et al.. (2014). Abstract 4403: Preclinical evaluation of LY2801653, an orally bioavailable small molecule oncokinase inhibitor, in cholangiocarcinoma models. Cancer Research. 74(19_Supplement). 4403–4403. 1 indexed citations
3.
Cook, Joel D.. (2006). Detection of Lymphatic Invasion in Primary Melanoma With Monoclonal Antibody D2-40: A New Selective Immunohistochemical Marker of Lymphatic Endothelium. Yearbook of Dermatology and Dermatologic Surgery. 2006. 333–334. 4 indexed citations
4.
Sivolapenko, Gregory, Κωνσταντίνος Κωνσταντινίδης, Dimitrios Pectasides, et al.. (1995). Breast cancer imaging with radiolabelled peptide from complementarity-determining region of antitumour antibody. The Lancet. 346(8991-8992). 1662–1666. 38 indexed citations
5.
Cook, Joel D. & B.H. Thiers. (1993). Serum calcium and phosphorus measurements in patients with psoriasis: a retrospective review. Journal of the European Academy of Dermatology and Venereology. 2(1). 18–21. 4 indexed citations
6.
Cook, Joel D., et al.. (1978). The effects of single‐dose alternate‐day prednisone therapy on the immunological status of patients with neuromuscular diseases. Annals of Neurology. 3(2). 166–176. 10 indexed citations
7.
Zee, David S., Lance M. Optican, Joel D. Cook, D. A. Robinson, & W. King Engel. (1976). Slow Saccades in Spinocerebellar Degeneration. Archives of Neurology. 33(4). 243–251. 214 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026